Switch to:

Teva Pharmaceutical Industries Days Sales Outstanding

: 108.67 (As of Mar. 2020)
View and export this data going back to 1990. Start your Free Trial

Teva Pharmaceutical Industries's Accounts Receivable for the three months ended in Mar. 2020 was $5,189 Mil. Teva Pharmaceutical Industries's Revenue for the three months ended in Mar. 2020 was $4,357 Mil. Hence, Teva Pharmaceutical Industries's days sales outstanding for the three months ended in Mar. 2020 was 108.67.

NYSE:TEVA' s Days Sales Outstanding Range Over the Past 10 Years
Min: 95.91   Med: 117.69   Max: 125.37
Current: 111.74

95.91
125.37

During the past 13 years, Teva Pharmaceutical Industries's highest Days Sales Outstanding was 125.37. The lowest was 95.91. And the median was 117.69.

NYSE:TEVA's Days Sales Outstanding is ranked lower than
76% of the 921 Companies
in the Drug Manufacturers industry.

( Industry Median: 75.41 vs. NYSE:TEVA: 111.74 )

Teva Pharmaceutical Industries's days sales outstanding declined from Mar. 2019 (112.40) to Mar. 2020 (108.67).


Teva Pharmaceutical Industries Days Sales Outstanding Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Teva Pharmaceutical Industries Annual Data
Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Days Sales Outstanding Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 99.37 125.37 119.06 116.31 122.68

Teva Pharmaceutical Industries Quarterly Data
Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20
Days Sales Outstanding Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 112.40 110.67 112.44 129.74 108.67

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Teva Pharmaceutical Industries Days Sales Outstanding Distribution

* The bar in red indicates where Teva Pharmaceutical Industries's Days Sales Outstanding falls into.



Teva Pharmaceutical Industries Days Sales Outstanding Calculation

Days sales outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Teva Pharmaceutical Industries's Days Sales Outstanding for the fiscal year that ended in Dec. 2019 is calculated as

Days Sales Outstanding=Accounts Receivable/Revenue*Days in Period
=5676/16887*365
=122.68

Teva Pharmaceutical Industries's Days Sales Outstanding for the quarter that ended in Mar. 2020 is calculated as:

Days Sales Outstanding=Accounts Receivable/Revenue*Days in Period
=5189/4357*365 / 4
=108.67

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Teva Pharmaceutical Industries  (NYSE:TEVA) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Teva Pharmaceutical Industries Days Sales Outstanding Related Terms


Teva Pharmaceutical Industries Days Sales Outstanding Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)